Skip to main content
Fig. 1 | Orphanet Journal of Rare Diseases

Fig. 1

From: Development and validation of the prognostic value of ferritin in adult patients with Hemophagocytic Lymphohistiocytosis

Fig. 1

Performance of serum ferritin in different subgroups of adult HLH patients in the test cohort. a Adult HLH patients with post-treatment serum ferritin > 1050 μg/L showed significantly worse OS than those with post-treatment serum ferritin ≤1050 μg/L. b Infection-associated adult HLH patients with post-treatment serum ferritin > 1050 μg/L showed significantly worse OS than those with post-treatment serum ferritin ≤1050 μg/L. c Malignancy-associated adult HLH patients with post-treatment serum ferritin > 1050 μg/L showed significantly worse OS than those with post-treatment serum ferritin ≤1050 μg/L. (D) Overall survival, stratified according to quartiles of serum ferritin decrease

Back to article page